{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:48Z","timestamp":1787240748767,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched MEDLINE, EMBASE, Cochrane Library, Web of Science Core Collection from inception to June 2018. For the MEDLINE search, we included the MeSH terms \u201cintrauterine devices\u201d AND \u201covarian neoplasms,\u201d however also searching \u201cintrauter*,\u201d \u201covar*\u201d and \u201cfallopian tube,\u201d as well as \u201ccancer\u201d and \u201ccarcinoma\u201d as keywords to include all possible variations. Similar search terms were used in the other databases. We also searched ClinicalTrials.gov.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Case\u2013control and cohort studies that collected individual level data on IUD use and ovarian cancer diagnosis were critically reviewed and data extracted. Review of abstracts from 399 articles through systematic database review and an additional 200 articles through Google Scholar identified a total of 15 studies with individual level data regarding IUD use and incident ovarian cancer. On critical review, 11 of these studies were used for meta-analysis. All case reports and reviews were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>\n                      The data were harmonized and weighted and summary odds ratios (ORs) were calculated. Covariates were identified evaluated separately. A random-effects meta-analysis was performed to confirm minimal bias. Harmonization and weighting of the data revealed an OR association between ever use of an IUD and incident ovarian cancer to be 0.68 (95% CI 0.62\u20130.75). There were no significant differences found between covariates. Heterogeneity among all studies was found to be I\n                      <jats:sup>2<\/jats:sup>\n                      =68%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Intrauterine device use is associated with a reduced incidence of ovarian cancer based on a review of existing retrospective data. Unfortunately, prospective investigation into the role of IUDs in ovarian cancer prevention is limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003463","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T07:43:25Z","timestamp":1568101405000},"page":"791-800","source":"Crossref","is-referenced-by-count":44,"title":["Intrauterine Device Use and Ovarian Cancer Risk"],"prefix":"10.1097","volume":"134","author":[{"given":"Lindsay J.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Desanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Teal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Sheeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saketh R.","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum Reprod"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/1055-9965.EPI-05-0035","article-title":"Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer","volume":"14","author":"Cramer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.29412","article-title":"Contraceptive methods and ovarian cancer risk among Chinese women: a report from the Shanghai Women's Health Study","volume":"137","author":"Huang","year":"2015","journal-title":"Int J Cancer"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ijc.24232","article-title":"Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006","volume":"124","author":"Dorjgochoo","year":"2009","journal-title":"Int J Cancer"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.28064","article-title":"Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin","volume":"133","author":"Kotsopoulos","year":"2013","journal-title":"Int J Cancer"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/bjc.2017.35","article-title":"Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer","volume":"116","author":"Kim","year":"2017","journal-title":"Br J Cancer"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0090-8258(03)00088-X","article-title":"Risk factors for ovarian cancer in Taiwan: a case\u2013control study in a low-incidence population","volume":"89","author":"Yen","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0277-5379(91)90226-4","article-title":"Oral contraceptive use and risk of ovarian cancer: an Italian case-control study","volume":"27","author":"Parazzini","year":"1991","journal-title":"Eur J Cancer"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.contraception.2012.02.019","article-title":"Reproductive factors in relation to ovarian cancer: a case-control study in Northern Vietnam","volume":"86","author":"Le","year":"2012","journal-title":"Contraception"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001648-200105000-00010","article-title":"Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer","volume":"12","author":"Ness","year":"2001","journal-title":"Epidemiology"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.annepidem.2010.10.002","article-title":"Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer","volume":"21","author":"Ness","year":"2011","journal-title":"Ann Epidemiol"},{"key":"R25-20230711","first-page":"3658","article-title":"Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico","volume":"59","author":"Salazar-Martinez","year":"1999","journal-title":"Cancer Res"},{"key":"R26-20230711","first-page":"3670","article-title":"Population-based case-control study of ovarian cancer in Shanghai","volume":"49","author":"Shu","year":"1989","journal-title":"Cancer Res"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-12-33","article-title":"A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection","volume":"12","author":"Clarke","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:58:36Z","timestamp":1689091116000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003463"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003463","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736581776.793566085","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}